Navigation Links
Sixth Generation Elekta Digital Control System Boosts Radiation Therapy System Speed and Performance
Date:2/10/2012

ATLANTA, Feb. 10, 2012 /PRNewswire/ -- The advanced functionality of Elekta's family of digital linear accelerators demands the highest degree of intelligent coordination. Elekta's latest control system, Integrity™ R1.1, meets this requirement through three tiers of safety, command of MLC interdigitation for exceptional field shaping, and support of virtually limitless options to adjust the radiation dose.

Integrity R1.1 has undergone rigorous tests in eight international centers, which demonstrated safe reductions in treatment delivery times of as high as 30 percent. The receipt of 510(k) clearance for Integrity R1.1 enables U.S. medical centers to realize these treatment speed and safety benefits when Elekta begins delivery of the control systems.

"I appreciate the use of multiple measures to ensure correct treatment delivery," says Jonas Fontenot, Ph.D., physicist at Mary Bird Perkins Cancer Center (Baton Rouge, La.), which has been evaluating a previous release of Integrity since February 2011. "In addition, during Volumetric Modulated Radiation Therapy [VMAT], Integrity constantly captures delivery parameters and sends them back to our MOSAIQ® oncology information system, where they become part of the patient's electronic record."

Interdigitation and Continuously Variable Dose Rate (CVDR) boost efficiency

With interdigitation of MLCi2 enabled by Integrity R1.1, MLC capabilities have caught up with the ability of the treatment planning system to create fields with complex geometry. Because MLC leaves can move past one another – or interdigitate – clinicians can employ island fields in difficult cases, such as those involving multiple targets.

"Interdigitation is important for treating multiple targets – such as multiple brain mets – and also when there is a target geometry that consists of different dose objectives," Dr. Fontenot says. "For example, we may want to treat a primary target to 70 Gy and a nodal region to 57 Gy."

Quicker, smoother VMAT

Integrity R1.1 supports CVDR, which allows the dose rate to be adjusted to its ideal value during delivery of both dynamic and VMAT prescriptions. This option makes prescription delivery smoother and faster when compared to previous discrete dose rates.

"The additional dose rate options permit the control system to easily navigate complex dose modulation paths," he explains. "Less variability in gantry speed smoothes VMAT arc motion, which also translates to reduced delivery times."

Learn more at www.elekta.com/integrity.

Approval of indications may vary between different countries. Additional regulatory clearances may be required in some markets.

About Elekta

Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website: www.elekta.com.


'/>"/>
SOURCE Elekta
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Bacterin to Present at Sixth Annual Singular Research Best of the Uncovereds Conference on October 26, 2011
2. Insmed to Present at Sixth Annual JMP Securities Healthcare Conference
3. Sangamo BioSciences Announces Presentation at the Sixth Annual JMP Securities Healthcare Conference
4. Arena Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
5. Alexza Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
6. Savient Pharmaceuticals to Present at the Sixth Annual JMP Securities Healthcare Conference
7. Premier Awards Sixth Consecutive Contract to Instrumentation Laboratory for Critical Care Portfolio
8. AssureRx Expands GeneSightRx® Pharmacogenetic Profile with Sixth Gene to Enhance Guidance of Psychiatric Drug Prescribing
9. Abbott Remains on the Dow Jones Sustainability Indexes for the Sixth Consecutive Year in Recognition of Leading Corporate Citizenship Performance
10. China Medical Technologies Announces its Subsidiary, GP Medical, Ranked Sixth in Deloitte Technology Fast 50 China 2010 Program
11. Statement of Ben Anderson, Esq., Regarding Denial of Wyeths En Banc Petition to Sixth Circuit Court of Appeals in Major Drug Regulation Pre-emption Case
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
(Date:4/20/2017)... Sweden , April 20, 2017 ... NEVPF) ("NeuroVive") today announced positive preclinical results ... preclinical compound for non-alcoholic steatohepatitis (NASH), in ... NV556 has previously shown ... NASH model. Today, NeuroVive,s scientists present novel ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 Cardiology ... during the projected period The Cardiology Devices segment ... more than US$ 15 Mn in 2018 over 2017. By ... reach a market valuation close to US$ 700 Mn, expanding ... Cardiology Devices segment dominated the Asia Pacific ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... Back Pain Centers ... back pain with a reputable physician in their area, announces the launch of a ... information for patients who are looking for reputable physicians to help them with back ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... addition of predictive analytics to its patient care management module. Using this new ... before a patient has been initiated on continuous positive airway pressure (CPAP), oral, ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® ... introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky ... horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG ... Your Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national ... which pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use kit ...
(Date:4/24/2017)... ... 2017 , ... Ridgecrest Herbals makes it a point to lead the Utah ... and support renewable energy. They believe this is a crucial part of their mission ... health issues, and maintain that destroying the environment in the pursuit of profit is ...
Breaking Medicine News(10 mins):